Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Harnessing Communication Preferences to Enhance Its Persistence and Mitigate Relapse of Challenging Behavior

NCT07278544 is registered in ClinicalTrials.gov with Joel E. Ringdahl as lead sponsor.

NCT NCT07278544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07278544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Harnessing Communication Preferences to Enhance Its Persistence and Mitigate Relapse of Challenging Behavior
Lead sponsor
Joel E. Ringdahl
Phase
Not applicable
Overall status
Recruiting
Start date
August 15, 2025
Completion date
March 31, 2031
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, communication disabilities, communication, nonverbal, intellectual disability, self-injurious behavior